ADARx Pharmaceuticals, Inc. Common Stock (ADRX) — Cash Flow Reinvestment Rate
ADARx Pharmaceuticals, Inc. Common Stock (ADRX) has a Cash Flow Reinvestment Rate of 0.84x as of June 2025, reinvesting $263.17 Million (capex $992.00K plus investments $-262.17 Million) from operating cash flow of $313.44 Million. See ADRX free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ADARx Pharmaceuticals, Inc. Common Stock Cash Flow Reinvestment Rate (2025–2025)
Historical reinvestment intensity for ADARx Pharmaceuticals, Inc. Common Stock across 1 annual periods. Explore cash flow to debt ratio of ADARx Pharmaceuticals, Inc. Common Stock to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for ADARx Pharmaceuticals, Inc. Common Stock (2025–2025)
Year-by-year capital reinvestment analysis for ADARx Pharmaceuticals, Inc. Common Stock. For the full cash flow conversion analysis, see ADRX cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.80x | $209.93 Million | $262.29 Million | $2.94 Million | — |